Target intelligence / Profile preview

Hepatocyte endoplasmic reticulum integrity

Molecular classification
Other
01

Overview

Hepatocyte endoplasmic reticulum (ER) integrity refers to the structural and functional stability of the ER within liver cells, which is essential for maintaining cellular proteostasis, lipid metabolism, and calcium regulation. As the primary site for the synthesis of secreted proteins and the metabolism of xenobiotics, the hepatocyte ER is highly sensitive to metabolic demands and toxic insults. Disruption of ER integrity leads to 'ER stress,' a pathological state characterized by the accumulation of unfolded or misfolded proteins and the subsequent activation of the Unfolded Protein Response (UPR). Chronic loss of ER integrity is a key driver in the progression of various liver diseases, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI). While it is not a single molecular target like a receptor or enzyme, maintaining or restoring ER integrity is a major therapeutic objective, often addressed using chemical chaperones or modulators of the UPR pathway to prevent hepatocyte apoptosis and liver fibrosis.

Other names
Hepatocyte ER homeostasisEndoplasmic reticulum stress responseER healthLiver ER integrityProteostasis
02

Mechanism of action

Restoration of ER proteostasis through chemical chaperoning to assist protein folding or through the modulation of the Unfolded Protein Response (UPR) to increase the cell's adaptive capacity and prevent apoptosis.

03

Biological functions

Protein synthesis and foldingLipid biosynthesisCalcium homeostasisXenobiotic metabolismCholesterol synthesisSignal transduction
04

Disease associations

Non-alcoholic fatty liver disease (NAFLD)Non-alcoholic steatohepatitis (NASH)Drug-induced liver injury (DILI)Viral hepatitisLiver cirrhosisAlpha-1 antitrypsin deficiencyHepatocellular carcinoma
05

Safety considerations

Potential pro-survival effects in malignant cells (promoting tumor growth)Off-target effects on systemic protein secretionInterference with essential physiological ER stress signaling in non-target tissuesDose-limiting toxicity of certain chemical chaperones
06

Interacting drugs

Tauroursodeoxycholic acid (TUDCA)

4 more in the full profile.

07

Biomarkers

GRP78 (BiP)CHOP (DDIT3)XBP1 splicing (XBP1s)ATF4p-eIF2alpha

Beyond the preview

Go deeper on Hepatocyte endoplasmic reticulum integrity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte endoplasmic reticulum integrity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call